A neurochemical closed-loop controller for deep brain stimulation

Toward individualized smart neuromodulation therapies

Peter J. Grahn, Grant W. Mallory, Obaid U. Khurram, B. Michael Berry, Jan T. Hachmann, Allan J. Bieber, Kevin E. Bennet, Hoon Ki Min, Su-Youne Chang, Kendall H Lee, Jose Lujan

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Current strategies for optimizing deep brain stimulation (DBS) therapy involve multiple postoperative visits. During each visit, stimulation parameters are adjusted until desired therapeutic effects are achieved and adverse effects are minimized. However, the efficacy of these therapeutic parameters may decline with time due at least in part to disease progression, interactions between the host environment and the electrode, and lead migration. As such, development of closed-loop control systems that can respond to changing neurochemical environments, tailoring DBS therapy to individual patients, is paramount for improving the therapeutic efficacy of DBS. Evidence obtained using electrophysiology and imaging techniques in both animals and humans suggests that DBS works by modulating neural network activity. Recently, animal studies have shown that stimulation-evoked changes in neurotransmitter release that mirror normal physiology are associated with the therapeutic benefits of DBS. Therefore, to fully understand the neurophysiology of DBS and optimize its efficacy, it may be necessary to look beyond conventional electrophysiological analyses and characterize the neurochemical effects of therapeutic and non-therapeutic stimulation. By combining electrochemical monitoring and mathematical modeling techniques, we can potentially replace the trial-and-error process used in clinical programming with deterministic approaches that help attain optimal and stable neurochemical profiles. In this manuscript, we summarize the current understanding of electrophysiological and electrochemical processing for control of neuromodulation therapies. Additionally, we describe a proof-of-principle closed-loop controller that characterizes DBS-evoked dopamine changes to adjust stimulation parameters in a rodent model of DBS. The work described herein represents the initial steps toward achieving a "smart" neuroprosthetic system for treatment of neurologic and psychiatric disorders.

Original languageEnglish (US)
Article numberArticle 169
JournalFrontiers in Neuroscience
Issue number8 JUN
DOIs
StatePublished - 2014

Fingerprint

Deep Brain Stimulation
Therapeutic Uses
Therapeutics
Neurophysiology
Electrophysiology
Nervous System Diseases
Neurotransmitter Agents
Psychiatry
Disease Progression
Rodentia
Dopamine
Electrodes

Keywords

  • Deep brain stimulation (DBS)
  • Fast scan cyclic voltammetry (FSCV)
  • Feedback control systems
  • Individualized medicine
  • Local field potentials (LFP)
  • Machine learning

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

A neurochemical closed-loop controller for deep brain stimulation : Toward individualized smart neuromodulation therapies. / Grahn, Peter J.; Mallory, Grant W.; Khurram, Obaid U.; Berry, B. Michael; Hachmann, Jan T.; Bieber, Allan J.; Bennet, Kevin E.; Min, Hoon Ki; Chang, Su-Youne; Lee, Kendall H; Lujan, Jose.

In: Frontiers in Neuroscience, No. 8 JUN, Article 169, 2014.

Research output: Contribution to journalArticle

Grahn, Peter J. ; Mallory, Grant W. ; Khurram, Obaid U. ; Berry, B. Michael ; Hachmann, Jan T. ; Bieber, Allan J. ; Bennet, Kevin E. ; Min, Hoon Ki ; Chang, Su-Youne ; Lee, Kendall H ; Lujan, Jose. / A neurochemical closed-loop controller for deep brain stimulation : Toward individualized smart neuromodulation therapies. In: Frontiers in Neuroscience. 2014 ; No. 8 JUN.
@article{68875fc4ea734496863dfe69997cc224,
title = "A neurochemical closed-loop controller for deep brain stimulation: Toward individualized smart neuromodulation therapies",
abstract = "Current strategies for optimizing deep brain stimulation (DBS) therapy involve multiple postoperative visits. During each visit, stimulation parameters are adjusted until desired therapeutic effects are achieved and adverse effects are minimized. However, the efficacy of these therapeutic parameters may decline with time due at least in part to disease progression, interactions between the host environment and the electrode, and lead migration. As such, development of closed-loop control systems that can respond to changing neurochemical environments, tailoring DBS therapy to individual patients, is paramount for improving the therapeutic efficacy of DBS. Evidence obtained using electrophysiology and imaging techniques in both animals and humans suggests that DBS works by modulating neural network activity. Recently, animal studies have shown that stimulation-evoked changes in neurotransmitter release that mirror normal physiology are associated with the therapeutic benefits of DBS. Therefore, to fully understand the neurophysiology of DBS and optimize its efficacy, it may be necessary to look beyond conventional electrophysiological analyses and characterize the neurochemical effects of therapeutic and non-therapeutic stimulation. By combining electrochemical monitoring and mathematical modeling techniques, we can potentially replace the trial-and-error process used in clinical programming with deterministic approaches that help attain optimal and stable neurochemical profiles. In this manuscript, we summarize the current understanding of electrophysiological and electrochemical processing for control of neuromodulation therapies. Additionally, we describe a proof-of-principle closed-loop controller that characterizes DBS-evoked dopamine changes to adjust stimulation parameters in a rodent model of DBS. The work described herein represents the initial steps toward achieving a {"}smart{"} neuroprosthetic system for treatment of neurologic and psychiatric disorders.",
keywords = "Deep brain stimulation (DBS), Fast scan cyclic voltammetry (FSCV), Feedback control systems, Individualized medicine, Local field potentials (LFP), Machine learning",
author = "Grahn, {Peter J.} and Mallory, {Grant W.} and Khurram, {Obaid U.} and Berry, {B. Michael} and Hachmann, {Jan T.} and Bieber, {Allan J.} and Bennet, {Kevin E.} and Min, {Hoon Ki} and Su-Youne Chang and Lee, {Kendall H} and Jose Lujan",
year = "2014",
doi = "10.3389/fnins.2014.00169",
language = "English (US)",
journal = "Frontiers in Neuroscience",
issn = "1662-4548",
publisher = "Frontiers Research Foundation",
number = "8 JUN",

}

TY - JOUR

T1 - A neurochemical closed-loop controller for deep brain stimulation

T2 - Toward individualized smart neuromodulation therapies

AU - Grahn, Peter J.

AU - Mallory, Grant W.

AU - Khurram, Obaid U.

AU - Berry, B. Michael

AU - Hachmann, Jan T.

AU - Bieber, Allan J.

AU - Bennet, Kevin E.

AU - Min, Hoon Ki

AU - Chang, Su-Youne

AU - Lee, Kendall H

AU - Lujan, Jose

PY - 2014

Y1 - 2014

N2 - Current strategies for optimizing deep brain stimulation (DBS) therapy involve multiple postoperative visits. During each visit, stimulation parameters are adjusted until desired therapeutic effects are achieved and adverse effects are minimized. However, the efficacy of these therapeutic parameters may decline with time due at least in part to disease progression, interactions between the host environment and the electrode, and lead migration. As such, development of closed-loop control systems that can respond to changing neurochemical environments, tailoring DBS therapy to individual patients, is paramount for improving the therapeutic efficacy of DBS. Evidence obtained using electrophysiology and imaging techniques in both animals and humans suggests that DBS works by modulating neural network activity. Recently, animal studies have shown that stimulation-evoked changes in neurotransmitter release that mirror normal physiology are associated with the therapeutic benefits of DBS. Therefore, to fully understand the neurophysiology of DBS and optimize its efficacy, it may be necessary to look beyond conventional electrophysiological analyses and characterize the neurochemical effects of therapeutic and non-therapeutic stimulation. By combining electrochemical monitoring and mathematical modeling techniques, we can potentially replace the trial-and-error process used in clinical programming with deterministic approaches that help attain optimal and stable neurochemical profiles. In this manuscript, we summarize the current understanding of electrophysiological and electrochemical processing for control of neuromodulation therapies. Additionally, we describe a proof-of-principle closed-loop controller that characterizes DBS-evoked dopamine changes to adjust stimulation parameters in a rodent model of DBS. The work described herein represents the initial steps toward achieving a "smart" neuroprosthetic system for treatment of neurologic and psychiatric disorders.

AB - Current strategies for optimizing deep brain stimulation (DBS) therapy involve multiple postoperative visits. During each visit, stimulation parameters are adjusted until desired therapeutic effects are achieved and adverse effects are minimized. However, the efficacy of these therapeutic parameters may decline with time due at least in part to disease progression, interactions between the host environment and the electrode, and lead migration. As such, development of closed-loop control systems that can respond to changing neurochemical environments, tailoring DBS therapy to individual patients, is paramount for improving the therapeutic efficacy of DBS. Evidence obtained using electrophysiology and imaging techniques in both animals and humans suggests that DBS works by modulating neural network activity. Recently, animal studies have shown that stimulation-evoked changes in neurotransmitter release that mirror normal physiology are associated with the therapeutic benefits of DBS. Therefore, to fully understand the neurophysiology of DBS and optimize its efficacy, it may be necessary to look beyond conventional electrophysiological analyses and characterize the neurochemical effects of therapeutic and non-therapeutic stimulation. By combining electrochemical monitoring and mathematical modeling techniques, we can potentially replace the trial-and-error process used in clinical programming with deterministic approaches that help attain optimal and stable neurochemical profiles. In this manuscript, we summarize the current understanding of electrophysiological and electrochemical processing for control of neuromodulation therapies. Additionally, we describe a proof-of-principle closed-loop controller that characterizes DBS-evoked dopamine changes to adjust stimulation parameters in a rodent model of DBS. The work described herein represents the initial steps toward achieving a "smart" neuroprosthetic system for treatment of neurologic and psychiatric disorders.

KW - Deep brain stimulation (DBS)

KW - Fast scan cyclic voltammetry (FSCV)

KW - Feedback control systems

KW - Individualized medicine

KW - Local field potentials (LFP)

KW - Machine learning

UR - http://www.scopus.com/inward/record.url?scp=84905053624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905053624&partnerID=8YFLogxK

U2 - 10.3389/fnins.2014.00169

DO - 10.3389/fnins.2014.00169

M3 - Article

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

SN - 1662-4548

IS - 8 JUN

M1 - Article 169

ER -